A detailed history of Cutter Capital Management, LP transactions in Moderna, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 197,500 shares of MRNA stock, worth $6.63 Million. This represents 3.37% of its overall portfolio holdings.

Number of Shares
197,500
Holding current value
$6.63 Million
% of portfolio
3.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$36.85 - $63.93 $7.28 Million - $12.6 Million
197,500 New
197,500 $8.21 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.